Article Figures & Data

Figures

  • Figure 1.

    Genetic Profile in Local Study of 262 Patients

    Reproduced with permission from F Barlesi, MD.

  • Figure 2.

    Master Protocol for Lung-MAP Study of Squamous Cell Lung Cancer

    CLIA, Clinical Laboratory Improvement Amendments; CT, chemotherapy (docetaxel or gemcitabine); E, erlotinib; NGS, next-generation sequencing; OS, overall survival; PFS, progression-free survival; TT, targeted therapy.

    Reproduced with permission from DR Gandara, MD.